Skip to main content

Select Drug Profiles

Conference Highlights ADA
Initiation of Therapy with a Sulfonylurea Increased Risk of Cardiovascular Events versus Metformin in Older Adults with Type 2 Diabetes
Alice Goodman
Read More
Conference Highlights ADA
Linagliptin as Effective as Glimepiride with Improved Safety Profile
Alice Goodman
Read More
Conference Highlights ADA
Diabetes Prevention with Metformin Is Cost-Saving for Persons at High Risk
Wayne Kuznar
Read More
Conference Highlights ADA
Nurse Educators as Part of Team Approach Improve Outcomes and Lower Costs Associated with Diabetes
Alice Goodman
Read More
Conference Highlights ADA
Blood Glucose Testing a Significant Contributor to Pharmacy Costs in Patients Using Insulin
Wayne Kuznar
Read More
Perspectives, Conference Highlights ADA
ADA President’s Views on Clinical Management of Type 2 Diabetes
Alice Goodman
Read More
Conference Highlights ADA
Insulin Inappropriately Discontinued in Many Type 2 Diabetes Patients After Hospitalization
Wayne Kuznar
Read More
Conference Highlights ADA
Type 2 Diabetes Treatment in Patients with CKD Should Conform to NKF Guidelines for Better Outcomes, Lower Costs
Alice Goodman
Read More
Perspectives
From Asheville to Hickory: Transforming Our “Sick Care” System into a True “Health Care” Model
Daniel G. Garrett, RPh, MS, FASHP
Read More
Original Research
The Hickory Project: Controlling Healthcare Costs and Improving Outcomes for Diabetes Using the Asheville Project Model
Barry A. Bunting, PharmD, DSNAP, Grover Lee, PharmD, BCMCM, Grant Knowles, PharmD, Christine Lee, PharmD, BCPS, CLS, Paul Allen, PhD, MBA
Stakeholder Perspective
Keeping a Lid on Health Plan Costs, One Patient at a Time
by Rick Miller
Read More
Page 212 of 244
Results 2111 - 2120 of 2438